However, the fact that Gas6 is scarcely expressed and sAxl and sMer decoy receptors are overexpressed in chronic MS lesions [101], and that the higher the CSF Gas6 concentration is, the milder the clinical MS relapse phenotype [110], are strong suggestions that activation of the TAM system in this setting is beneficial. This evidence concerns the gene GAS6 and myeloid sarcoma.